J Dvorak1, N Feddermann, K Grimm. 1. FIFA Medical Assessment and Research Centre, Department of Neurology, Schulthess Clinic, Zurich, Switzerland. jiri.dvorak@kws.ch
Abstract
BACKGROUND AND OBJECTIVES: Glucocorticosteroids are widely used in medicine and have shown unchallenged therapeutic potential in several chronic inflammatory and other diseases. They are also widely used in sports medicine for the treatment of conditions such as asthma and acute injuries. In fact, as banned substances, most requests for therapeutic use exemption concern glucocorticosteroids. Nevertheless, their beneficial effect in certain conditions in sports, where inflammation is only a secondary reaction, remains to be validated. This paper aimed to provide a comprehensive review of the literature covering the therapeutic use of glucocorticosteroids since 1977 in conditions ranging from chronic rheumatic illness to peritendinous or intra-articular injection in acute injuries. METHODS: Search of the medical literature published between 1977 and 2006 using PubMed. Articles relevant to the question "When and if at all is the use of glucocorticosteroids justified in football?" were selected and analysed. RESULTS AND CONCLUSIONS: The findings clearly point out that, despite the common use of glucocorticosteroids in acute injuries in sports, there is actually limited evidence of the true benefits of such a practice. Physicians must take the possible adverse effects into consideration. In an athlete with clinically verified asthma, inhalational glucocorticosteroids remain first line therapy. Finally, for the purposes of education and prevention of misuse, it should be stressed that a measurable performance enhancing effect of glucocorticoids could not be proved on the basis of the results of the scientific studies to date.
BACKGROUND AND OBJECTIVES:Glucocorticosteroids are widely used in medicine and have shown unchallenged therapeutic potential in several chronic inflammatory and other diseases. They are also widely used in sports medicine for the treatment of conditions such as asthma and acute injuries. In fact, as banned substances, most requests for therapeutic use exemption concern glucocorticosteroids. Nevertheless, their beneficial effect in certain conditions in sports, where inflammation is only a secondary reaction, remains to be validated. This paper aimed to provide a comprehensive review of the literature covering the therapeutic use of glucocorticosteroids since 1977 in conditions ranging from chronic rheumatic illness to peritendinous or intra-articular injection in acute injuries. METHODS: Search of the medical literature published between 1977 and 2006 using PubMed. Articles relevant to the question "When and if at all is the use of glucocorticosteroids justified in football?" were selected and analysed. RESULTS AND CONCLUSIONS: The findings clearly point out that, despite the common use of glucocorticosteroids in acute injuries in sports, there is actually limited evidence of the true benefits of such a practice. Physicians must take the possible adverse effects into consideration. In an athlete with clinically verified asthma, inhalational glucocorticosteroids remain first line therapy. Finally, for the purposes of education and prevention of misuse, it should be stressed that a measurable performance enhancing effect of glucocorticoids could not be proved on the basis of the results of the scientific studies to date.
Authors: Ian Roberts; David Yates; Peter Sandercock; Barbara Farrell; Jonathan Wasserberg; Gabrielle Lomas; Rowland Cottingham; Petr Svoboda; Nigel Brayley; Guy Mazairac; Véronique Laloë; Angeles Muñoz-Sánchez; Miguel Arango; Bennie Hartzenberg; Hussein Khamis; Surakrant Yutthakasemsunt; Edward Komolafe; Fatos Olldashi; Yadram Yadav; Francisco Murillo-Cabezas; Haleema Shakur; Phil Edwards Journal: Lancet Date: 2004 Oct 9-15 Impact factor: 79.321
Authors: Rafael A Casuso; Lars Melskens; Thomas Bruhn; Niels H Secher; Nikolai Baastrup Nordsborg Journal: Eur J Appl Physiol Date: 2013-12-11 Impact factor: 3.078
Authors: Norbert Baume; Graeme Steel; Tony Edwards; Eric Thorstensen; Benjamin F Miller Journal: Eur J Appl Physiol Date: 2008-06-27 Impact factor: 3.078